We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current 0HB0 market cap is 4.86B. The company's latest EPS is USD 11.8135 and P/E is 2.78.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 203.2M | 41.41M | 14.24M | 26.82M | 36.5M |
| Operating Income | -316.15M | -387.83M | -389.05M | -391.49M | -425.74M |
| Net Income | -327.37M | 1.6B | -231.8M | -352.09M | 673.73M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 852.95M | 1.44B | 1.24B | 937.12M | 1.66B |
| Total Liabilities | 453.45M | 145.76M | 137.9M | 126.1M | 122.24M |
| Total Equity | 399.5M | 1.29B | 1.1B | 811.02M | 1.54B |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -290.76M | -407.32M | -309.48M | -296.06M | -389.84M |
| Investing | 75.75M | 1.25B | 243.26M | 239.58M | 363.44M |
| Financing | 261.52M | -765.77M | 2.35M | 5.43M | 14.44M |
| Market Cap | 4.86B |
| Price to Earnings Ratio | 2.78 |
| Price to Sales Ratio | 51.27 |
| Price to Cash Ratio | 24.54 |
| Price to Book Ratio | 1.21 |
| Dividend Yield | - |
| Shares Outstanding | 57.03M |
| Average Volume (1 week) | 218 |
| Average Volume (1 Month) | 236 |
| 52 Week Change | 0.00% |
| 52 Week High | 85.29 |
| 52 Week Low | 85.29 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Agios Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.agios.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
